The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease

[1]  G. Frisoni,et al.  The European diffusion tensor imaging study in dementia (EDSD): Physical phantom study and multimodal clinical study on the diagnosis of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[2]  M. Moseley,et al.  Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease , 2012, Neurobiology of Aging.

[3]  Mathew Varghese,et al.  Apolipoprotein E4 and Brain White Matter Integrity in Alzheimer’s Disease: Tract-Based Spatial Statistics Study under 3-Tesla MRI , 2012, Neurodegenerative Diseases.

[4]  Stefan Klöppel,et al.  Multicenter stability of diffusion tensor imaging measures: A European clinical and physical phantom study , 2011, Psychiatry Research: Neuroimaging.

[5]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[6]  I. Veer,et al.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study , 2008, Brain : a journal of neurology.

[7]  Jerry L. Prince,et al.  Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T , 2007, NeuroImage.

[8]  S. Love,et al.  Contributors to white matter damage in the frontal lobe in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.

[9]  Faith M. Gunning-Dixon,et al.  Differential aging of the human striatum: longitudinal evidence. , 2003, AJNR. American journal of neuroradiology.

[10]  Haruyasu Yamada,et al.  Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis , 2002, Neurobiology of Aging.

[11]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[12]  E. Mori,et al.  Effect of the Apolipoprotein E ε4 Allele on White Matter Hyperintensities in Dementia , 2000 .

[13]  H. Kawakami,et al.  Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[14]  P. Scheltens,et al.  Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias , 1999 .

[15]  L. Wahlund,et al.  White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype , 1999, Dementia and Geriatric Cognitive Disorders.

[16]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[18]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[19]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[20]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[21]  Stefan Klöppel,et al.  Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter study. , 2012, Journal of Alzheimer's disease : JAD.

[22]  E. Mori,et al.  Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. , 2000, Stroke.

[23]  P. Scheltens,et al.  Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. , 1999, Archives of neurology.